| ADR Ontology |
| ADR Term |
Liver disorder |
| ADR ID |
BADD_A02564 |
| ADR Hierarchy |
|
| Description |
Not Available |
| MedDRA Code |
10024670 |
| MeSH ID |
Not Available
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Advanced chronic liver disease | Chronic hepatopathy due to metabolic defect | Chronic liver disease | Disorder hepatic | Disorder liver | Ground glass appearance | Hepatic disease | Hepatic disease (NOS) | Hepatic disease NOS | Hepatic disorder NOS | Hepatic pathology | Liver disorder | Liver disorders antepartum | Liver disorders in pregnancy | Liver disorders in pregnancy, unspecified as to episode of care | Liver disorders in pregnancy, with delivery | Other chronic nonalcoholic liver disease | Other disorders of liver | Other sequelae of chronic liver disease | Other specified disorders of liver | Subacute liver disease | Unspecified chronic liver disease without mention of alcohol | Unspecified disorder of liver | Hepatic disorder aggravated | Hepatic disorder (NOS) | Hepatosis | Hepatosis aggravated | Hepatic impairment | Hepatopathy |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Endothelin-1 | P05305 | T25076 | | Glycogen synthase kinase-3 beta | P49841 | T70977 | | Low-density lipoprotein receptor-related protein 11 | Q86VZ4 | Not Available | | Nitric oxide synthase, endothelial | P29474 | T06046 | | Solute carrier family 2, facilitated glucose transporter member 4 | P14672 | T67658 |
|
| Drugs Leading to the ADR |
|
|
